Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom and the United States; - subcontracted manufacturing services (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

End-of-day quote Euronext Paris Other stock markets 2025-07-08			5-day change	1st Jan Change
2.400 ^EUR	-.--%		-.--%	-96.67%

05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement

Market Cap	160K 183K 148K 138K 259K 17.27M 261K 1.75M 683K 8.49M 686K 671K 29.49M	P/E 2023 *	-	P/E 2024	-77.6x
Enterprise Value	11.63M 13.31M 10.76M 10.04M 18.85M 1.26B 18.99M 128M 49.74M 618M 49.97M 48.89M 2.15B	EV / Sales 2023	46.6x	EV / Sales 2024	2.39x
Free-Float	95.95%	Yield 2023 *	-	Yield 2024	-

05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan
23-10-16	Safe Orthopaedics Announces Consolidated Sales Results for the Third Quarter and Nine Months of 2023	CI
23-09-06	Safe Group Launches Rehabilitation Proceedings	MT

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe Orthopaedics SA Stock Euronext Paris

Stocks

ALSAF

FR001400RKU0

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics SA

Chart: Safe Orthopaedics SA

Latest news : Safe Orthopaedics SA

Press Releases: Safe Orthopaedics SA

News in other languages: Safe Orthopaedics SA

Managers and Directors: Safe Orthopaedics SA

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE
03-16	SAFE - Modification de la composition du Conseil d'Administration

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS SA	-.--%	-.--%	-	-	65.25K
STRYKER CORPORATION	-1.01%	-1.06%	-18.87%	+2.28%	117B
SMITH & NEPHEW PLC	-0.40%	-1.59%	+3.10%	-9.95%	12.52B
GLAUKOS CORPORATION	+0.39%	+0.81%	+30.99%	+95.43%	7.7B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.89%	-1.54%	-46.25%	-70.77%	4.1B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.23%	-1.72%	+18.00%	+36.84%	2.52B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-2.67%	-3.28%	-16.52%	-15.40%	1.72B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.78%	-3.00%	+3.45%	-21.06%	1.58B
L&C BIO CO.,LTD	+4.14%	+15.49%	+201.37%	+165.46%	1.54B
Average	-0.07%	+0.15%	+21.91%	+22.85%	18.56B
Weighted average by Cap.	-0.80%	-0.93%	-12.01%	+5.89%

	2023	2024
Net sales	5.81M 6.65M 5.37M 5.02M 9.42M 628M 9.49M 63.86M 24.85M 309M 24.96M 24.42M 1.07B	5.04M 5.77M 4.66M 4.35M 8.17M 545M 8.23M 55.41M 21.56M 268M 21.66M 21.19M 931M
Net income	-205M -235M -190M -177M -333M -22.22B -335M -2.26B -879M -10.92B -883M -864M -37.95B	-1.93B -2.21B -1.78B -1.67B -3.13B -209B -3.15B -21.21B -8.25B -103B -8.29B -8.11B -356B
Net Debt	270M 309M 250M 233M 438M 29.25B 442M 2.97B 1.16B 14.38B 1.16B 1.14B 49.95B	11.47M 13.13M 10.61M 9.9M 18.59M 1.24B 18.73M 126M 49.06M 610M 49.29M 48.22M 2.12B